Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of the nation's largest pharmacy benefit managers, has […]

(Shenzhen:300627.SZ), HANOVER, Germany, Dec. 01, 2025 (GLOBE NEWSWIRE) — CHC Navigation (CHCNAV), a global leader in precision agriculture technologies, has announced a strategic partnership with CNH Industrial (CNH) at Agritechnica 2025 in Hanover. This collaboration brings CHCNAV's high-precision guidance systems into CNH's new FP FleetPro aftermarket kits, providing accessible and reliable precision agriculture tools to

(NasdaqGM:MNKD), If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds Would potentially provide a cost-effective and convenient option to address episodes of fluid buildup at home, benefiting patients, providers and payors PDUFA target action date of July 26, 2026 WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass.,

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow(TM) Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease GlobeNewswire December 01, 2025 If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds

CHC Navigation Partners with CNH to Power New FP FleetPro Precision Agriculture Kits GlobeNewswire December 01, 2025 HANOVER, Germany, Dec. 01, 2025 (GLOBE NEWSWIRE) — CHC Navigation (CHCNAV), a global leader in precision agriculture technologies, has announced a strategic partnership with CNH Industrial (CNH) at Agritechnica 2025 in Hanover. This collaboration brings CHCNAV's high-precision guidance

TSXV: ESBL — Gross Profit improved from 22% to 29% over the previous year's corresponding 3-month period. — Revenues increased by US$1.4 million or 16.1% over the corresponding previous year 9-month period. — Gross profit improved from 22.8% to 27% compared with the 9-month period of the prior year. Eshbal Functional Food Inc. (TSXV: ESBL)

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Stuhini Exploration Ltd. (TSXV: STU) (OTCQB: STXPF) (WKN: A2PLBV) (“Stuhini” or the “Company”) is pleased to announce highly favourable metallurgical test results from a 1585 pound (719 kg) surface mini-bulk sample collected in September 2025 from the Silver Surprise Zone at its 100%-owned Ruby Creek Project,

Toronto, Ontario–(Newsfile Corp. – December 1, 2025) – Magna Terra Minerals Inc. (TSXV: MTT) (the “Company” or “Magna Terra“) is pleased to announce results from its initial exploration work program on the Fournier Lake Gold Property, Rocky Brook Project (“Rocky Brook” or the “Project”), located in the prolific Bathurst Mining Camp (“BMC”) of northern New Brunswick (Figure

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2025) – Zodiac Gold Inc. (TSXV: ZAU) (“Zodiac Gold” or the “Company”), a West African gold exploration company, is pleased to announce the results of its initial trenching program at the highly prospective Ben Ben target, part of the Company’s flagship Todi Gold Project in Liberia. Ben Ben is one

NobleCon is the preeminent showcase of small and microcap companies Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focusedbiopharmaceutical company,today announced that Robb Knie, Chief Executive Officer, is scheduled to present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference in Boca Raton, FL. https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg To learn more about NobleCon and registration to attend